The genes that we included, RAS, BRAF, APC, SMAD4, and TP53, are driver mutations in major oncogenic pathways and have been implicated as prognostic or predictive biomarkers in prior metastatic colorectal cancer studies. This evidence concerns the gene TP53 and metastatic colorectal cancer.